PlainRecalls
FDA Drug Low Class III Terminated

Gabapentin Tablets USP, 600 mg, Rx Only, 500-count bottle, Manufactured for: Exelan Pharmaceuticals, Inc., Lawrenceville, GA 30046, Manufactured by: InvaGen Pharmaceuticals, Inc., Hauppauge, NY 11788, NDC 76282-405-05.

Reported: May 27, 2020 Initiated: May 14, 2020 #D-1272-2020

Product Description

Gabapentin Tablets USP, 600 mg, Rx Only, 500-count bottle, Manufactured for: Exelan Pharmaceuticals, Inc., Lawrenceville, GA 30046, Manufactured by: InvaGen Pharmaceuticals, Inc., Hauppauge, NY 11788, NDC 76282-405-05.

Reason for Recall

Failed Impurities/Degradation Specifications; failure of Impurity A test at the 12-month long-term stability testing.

Details

Units Affected
2,202 bottles
Distribution
Nationwide in the U.S.
Location
Hauppauge, NY

Frequently Asked Questions

What product was recalled?
Gabapentin Tablets USP, 600 mg, Rx Only, 500-count bottle, Manufactured for: Exelan Pharmaceuticals, Inc., Lawrenceville, GA 30046, Manufactured by: InvaGen Pharmaceuticals, Inc., Hauppauge, NY 11788, NDC 76282-405-05.. Recalled by InvaGen Pharmaceuticals, Inc.. Units affected: 2,202 bottles.
Why was this product recalled?
Failed Impurities/Degradation Specifications; failure of Impurity A test at the 12-month long-term stability testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 27, 2020. Severity: Low. Recall number: D-1272-2020.